Many women present with significant ovulation problems that may indicate an underlying issue with their metabolism and nutrition.
Many women present with significant ovulation problems that may indicate an underlying issue with their metabolism and nutrition. The common symptoms that may indicate polycystic ovarian syndrome (PCOS) include very irregular or absent periods (100%), large and cystic ovaries (95%), obesity (75%), problems with excessive body hair growth and/or acne (70%), cholesterol and/or triglyceride abnormalities (70%), and a strong family history of diabetes, hypertension, heart diseases, obesity, and irregular periods (100%).
It has been demonstrated that PCOS is due to an underlying metabolic problem known as insulin resistance. When the body's muscle and fat tissues become resistant to insulin action, the pancreas produces increasing amounts of insulin, leading to very high insulin levels. The high insulin levels tend to produce food cravings, particularly in the form of carbohydrates, making the cycle continue. High insulin levels make weight loss virtually impossible, and tend to promote weight gain. High insulin levels also drive the ovary to produce high amounts of male hormone (androgens), and cause follicles to literally die before they release mature eggs. As such, multiple cysts form in the ovaries, and no healthy eggs are released. Thus, infertility and a lack of ovulation are the hallmarks of PCOS.
The physicians at Reproductive Associates of Delaware take the issue of PCOS extremely seriously, with clinical research efforts targeted towards the insulin resistance issue. It is possible to provide a detailed evaluation and treatment regimen for women with PCOS, and the prognosis for achieving a healthy pregnancy and a healthier lifestyle is good.
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Excessive gonadotropins in IVF: Effects on mosaicism and live birth
April 12th 2024A recent study revealed a correlation between high doses and prolonged duration of exogenous gonadotropin use during in vitro fertilization and increased embryonic mosaicism alongside diminished live birth rates, prompting reconsideration of dosage and duration protocols.
Read More